117 related articles for article (PubMed ID: 23432920)
1. Prevention of acute GVHD in mice by treatment with Tripterygium hypoglaucum Hutch combined with cyclosporin A.
Li ZY; Wu Q; Yan Z; Li D; Pan X; Qiu T; Xu K
Hematology; 2013 Nov; 18(6):352-9. PubMed ID: 23432920
[TBL] [Abstract][Full Text] [Related]
2. [Experimental study of Tripterygium hypoglaucum (level) Hutch on preventing acute graft-versus-host disease in bone marrow transplantation mice].
Li S; Xu KL; Li ZY; Pan XY; Sun HY; Li DP; Cao J; Du B
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):727-30. PubMed ID: 18457261
[TBL] [Abstract][Full Text] [Related]
3. [Effects of Tripterygium hypoglaucum (level) Hutch extraction on regulatory T cells in mice after allogeneic bone marrow transplantation].
Li S; Xu KL; Li ZY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Oct; 29(10):910-4. PubMed ID: 20073223
[TBL] [Abstract][Full Text] [Related]
4. Effect of glucosidorum tripterygii tororum on acute graft-versus-host disease in mice.
Yu YQ; Zhang YX; Jin YN; Lu XM; Wang W; Zhang HP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):928-33. PubMed ID: 17096891
[TBL] [Abstract][Full Text] [Related]
5. Blocking activator protein 1 activity in donor cells reduces severity of acute graft-versus-host disease through reciprocal regulation of IL-17-producing T cells/regulatory T cells.
Park MJ; Moon SJ; Lee SH; Kim EK; Yang EJ; Min JK; Park SH; Kim HY; Yang CW; Cho ML
Biol Blood Marrow Transplant; 2014 Aug; 20(8):1112-20. PubMed ID: 24813170
[TBL] [Abstract][Full Text] [Related]
6. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
Strober S
Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
[TBL] [Abstract][Full Text] [Related]
7. THH Relieves CIA Inflammation by Reducing Inflammatory-related Cytokines.
Zhou X; Liu Q; Zhou X; Zhang J; Liu W; Zhao X; Luo N
Cell Biochem Biophys; 2020 Sep; 78(3):367-374. PubMed ID: 32363523
[TBL] [Abstract][Full Text] [Related]
8. [Influence of mouse genetic engineering regulatory T cells infusion on post-allogeneic bone marrow transplantation acute graft-versus-host disease in mice].
Cao J; Li L; Chen C; Zeng LY; Li ZY; Pan XY; Xu KL
Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):83-8. PubMed ID: 21429372
[TBL] [Abstract][Full Text] [Related]
9. CXCR3 blockade combined with cyclosporine A alleviates acute graft-versus-host disease by inhibiting alloreactive donor T cell responses in a murine model.
Miao S; Tang B; Liu H; Wang Z; Shi Y; Dong Y; Liu W; Qin C; Ren H
Mol Immunol; 2018 Feb; 94():82-90. PubMed ID: 29288898
[TBL] [Abstract][Full Text] [Related]
10. IL-22 deficiency in donor T cells attenuates murine acute graft-versus-host disease mortality while sparing the graft-versus-leukemia effect.
Couturier M; Lamarthée B; Arbez J; Renauld JC; Bossard C; Malard F; Bonnefoy F; Mohty M; Perruche S; Tiberghien P; Saas P; Gaugler B
Leukemia; 2013 Jul; 27(7):1527-37. PubMed ID: 23399894
[TBL] [Abstract][Full Text] [Related]
11. [Effect of delayed sequential bone marrow transplantation on acute graft-versus-host disease in major H-2 incompatible mouse transplantation].
Wang CL; Xu KL; Pan XY; Du B
Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):92-6. PubMed ID: 18681308
[TBL] [Abstract][Full Text] [Related]
12. Adoptive Transfer of Treg Cells Combined with Mesenchymal Stem Cells Facilitates Repopulation of Endogenous Treg Cells in a Murine Acute GVHD Model.
Lee ES; Lim JY; Im KI; Kim N; Nam YS; Jeon YW; Cho SG
PLoS One; 2015; 10(9):e0138846. PubMed ID: 26393514
[TBL] [Abstract][Full Text] [Related]
13. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
[TBL] [Abstract][Full Text] [Related]
14. Total alkaloids of Tripterygium hypoglaucum (levl.) Hutch inhibits tumor growth both in vitro and in vivo.
Jiang X; Huang XC; Ao L; Liu WB; Han F; Cao J; Zhang DY; Huang CS; Liu JY
J Ethnopharmacol; 2014; 151(1):292-8. PubMed ID: 24212079
[TBL] [Abstract][Full Text] [Related]
15. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
16. [Effects of immature dendritic cells genetically modified to express sTNFR I on graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) in allogeneic bone marrow transplantation mice].
Wang SH; Li DP; Zhang YJ; Zhang P; Zeng LY; Pan XY; Xu KL; Huang YH
Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):88-93. PubMed ID: 22730654
[TBL] [Abstract][Full Text] [Related]
17. Tripterygium hypoglaucum (level) Hutch induces aneuploidy of chromosome 8 in mouse bone marrow cells and sperm.
Xu W; Ziqing L; Yinrun D; Xiaoyan W; Jinglun X
Mutagenesis; 2004 Sep; 19(5):379-82. PubMed ID: 15388810
[TBL] [Abstract][Full Text] [Related]
18. IFN-γ production by allogeneic Foxp3+ regulatory T cells is essential for preventing experimental graft-versus-host disease.
Koenecke C; Lee CW; Thamm K; Föhse L; Schafferus M; Mittrücker HW; Floess S; Huehn J; Ganser A; Förster R; Prinz I
J Immunol; 2012 Sep; 189(6):2890-6. PubMed ID: 22869903
[TBL] [Abstract][Full Text] [Related]
19. [Influence of donor mouse age on the establishment of murine acute graft versus host disease model after allogenic hematopoietic stem cell transplantation].
Tang B; Zhu H; Li XM; Chu YN; Liu YL; Zhou F; Zhang Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1365-70. PubMed ID: 25338590
[TBL] [Abstract][Full Text] [Related]
20. Prevention of acute graft-versus-host disease by magnetic nanoparticles of Fe₃O₄ combined with cyclosporin A in murine models.
Cheng J; Zhou Y; Chen B; Wang J; Xia G; Jin N; Ding J; Gao C; Chen G; Miao Y; Li W; Liu Z; Wang X
Int J Nanomedicine; 2011; 6():2183-9. PubMed ID: 22114482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
